Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000-2016

Hellmund, P; Schmitt, J; Roessler, M; Meier, F; Schoffer, O

Schoffer, O (corresponding author), Tech Univ Dresden, Ctr Evidence Based Healthcare, Fac Med, D-01307 Dresden, Germany.; Schoffer, O (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, D-01307 Dresden, Germany.

CANCERS, 2020; 12 (9):

Abstract

Targeted therapies (TT) and immune checkpoint inhibitors (ICI) have become increasingly important in the treatment of metastatic malignant melanoma in......

Full Text Link